Events

Info session for 3 cascade funding calls
NOV
Thu
30
10:00 - 11:30

This was 1 year ago

Location

Online

Programmes
Digital, Industry & Space

Cascade funding, also known as financial support to third parties (FSTP), is an instrument of the European Commission to manage funding calls with smaller grant sizes. The main objective is to simplify the administrative processes faced by European companies, allowing them to faster access to finance. A complete overview of all FSTP calls can be found on the F&T portal.

Sploro (an organisation that participates as a project partner in some projects managing FSTP)is organizing an info day to provide first-hand information on the following open calls:

NGI Sargasso: Unique collaborative ecosystem and programme for promoting the transatlantic cooperation in NGI technologies.

NGI Sargasso 2nd Open Call will support projects lead by Member States and Associated Countries in the field of Next Generation Internet that count with an effective collaboration with US and/or Canadian institutions. Funding will be distributed only to the entities from Member States and Associated Countries, although an effective collaboration is required.

FIDAL: Field Trials Beyond 5G

FIDAL invites European third parties such as companies, research centers or any other relevant entity as well as facilities and infrastructure owners, to undertake a set of new or complementary 5G use cases to further enrich the main areas of interest and to perform related large-scale trials.

TrialsNet: TRials Supported By Smart Networks Beyond 5G

TrialsNet invites European third parties such as verticals, companies (including SMEs), research centers or any other relevant entity, as well as facilities and infrastructure owners, to participate in its large-scale trials activities through the implementation of additional, diversified, and heterogeneous vertical use cases.

More information and registration on the event website.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.